BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 10951138)

  • 21. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
    Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
    Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency.
    Gammon B; Robson A; Deonizio J; Arkin L; Guitart J
    J Am Acad Dermatol; 2014 Sep; 71(3):555-60. PubMed ID: 24813299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides.
    Simo OC; Warren SJ; Mark L; Hoffmann K; Alomari AK
    Int J Dermatol; 2019 Jul; 58(7):800-805. PubMed ID: 30520526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.
    Asadullah K; Haeussler-Quade A; Gellrich S; Hanneken S; Hansen-Hagge TE; Döcke WD; Volk HD; Sterry W
    Exp Dermatol; 2000 Aug; 9(4):248-51. PubMed ID: 10949545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathology of cutaneous T-cell lymphoma.
    Robson A
    Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):9-12. PubMed ID: 17474353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
    Su IJ; Tsai TF; Cheng AL; Chen CC
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L.
    Sigel JE; Hsi ED
    Mod Pathol; 2000 Apr; 13(4):446-51. PubMed ID: 10786813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of Fas and Fas-ligand expression during melanoma progression.
    Soubrane C; Mouawad R; Antoine EC; Verola O; Gil-Delgado M; Khayat D
    Br J Dermatol; 2000 Aug; 143(2):307-12. PubMed ID: 10951137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
    Mitteldorf C; Robson A; Tronnier M; Pfaltz MC; Kempf W
    Dermatology; 2015; 231(2):164-70. PubMed ID: 26111483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
    Kleinhans M; Tun-Kyi A; Gilliet M; Kadin ME; Dummer R; Burg G; Nestle FO
    Blood; 2003 Feb; 101(4):1487-93. PubMed ID: 12393570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 immunoreactivity is uncommon in primary cutaneous lymphoma.
    McGregor JM; Dublin EA; Levison DA; MacDonald DM; Smith NP; Whittaker S
    Br J Dermatol; 1995 Mar; 132(3):353-8. PubMed ID: 7718450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
    Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
    Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
    Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
    Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
    de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
    Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
    Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.
    Noe MH; Drake A; Link BK; Liu V
    J Cutan Pathol; 2013 Aug; 40(8):714-9. PubMed ID: 23651057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.